Straits Times Index
3,301.49 +8.80 (+0.27%) Nikkei
38,229.59 -44.46 (-0.12%) Hang Seng
18,155.28 +392.25 (+2.21%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,338.28 -2,869.64 (-4.77%) CMC Crypto 200
1,261.00 -78.07 (-5.83%)
Dyadic International, Inc. (DYAI)
- GlobeNewswire
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
JUPITER, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as in non-pharmaceutical applications including food, nutrition, and wellness, today announced that it will report its financial results for the first quarter 2024 and host a corporate update conference call on
- Insider Monkey
Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript
Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript March 28, 2024 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07. DYAI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good evening, and welcome […]
- Thomson Reuters StreetEvents
Q4 2023 Dyadic International Inc Earnings Call
Q4 2023 Dyadic International Inc Earnings Call
